University of Texas Southwestern Medical Center: Breast Neoplasms trials

The registry lists 26 Breast Neoplasms studies with University of Texas Southwestern Medical Center as lead sponsor. 3 are open to participants now and 7 have results posted.

Early Phase 1 2Phase 1 4Phase 2 9No phase 11(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS TrialRecruitingNCT06444269Phase 2
• CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast CancerRecruitingNCT05029999Phase 1
• Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant AbemaciclibRecruitingNCT04614194Phase 2
• Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP]Active, not recruitingNCT03747120Phase 2Results posted
• Increasing Physical Activity Among Breast Cancer Survivors With DepressionCompletedNCT02781051Not applicableResults posted
• Active Breathing Coordinator-based vs VisionRT-based Deep Inspiration Breath-hold for Radiation for Breast CancerCompletedNCT02694029Not applicableResults posted
• End-of-Life Care for African AmericansCompletedNCT02320123Not applicableResults posted
• HylaCare in the Treatment of Acute Skin Changes in Patients Undergoing Radiotherapy for Breast CancerCompletedNCT02165605Not applicableResults posted
• Sorafenib and Paclitaxel in Treating Patients With Metastatic Breast CancerTerminatedNCT00622466Phase 2Results posted
• Capecitabine and Radiation Therapy in Treating Patients With Nonmetastatic Breast Cancer After SurgeryCompletedNCT00562718Phase 2Results posted
• Prospective Registry Trial for Single Port Robot-assisted Nipple Sparing Mastectomy (SPrNSM)CompletedNCT04866992
• PARP Inhibition During Pre-surgical Window in Breast/Ovary CancerCompletedNCT04041128Early Phase 1
• A Phase I Dose Escalation Study of Single Fraction Pre-operative Partial Breast (S-PBI) for Early Stage Breast CancerActive, not recruitingNCT04040569Phase 1
• Infrared Imaging for Breast Cancer ModelingCompletedNCT03990012Not applicable
• Using Hyperpolarized [1-13C]Pyruvate to Detect CardiotoxicityCompletedNCT03685175Early Phase 1
• Phase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using GammapodActive, not recruitingNCT03581136Not applicable
• Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast CancerActive, not recruitingNCT03546686Phase 2
• Test - Retest Reproducibility of 18F Fluoroestradiol (FES) PETWithdrawnNCT03065712Phase 2
• Investigation of Diagnostic Improvement Gained Through Optimization of MR Methods for Breast Cancer DetectionCompletedNCT02411760
• Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1)CompletedNCT01976169Phase 1
• Ixabepilone and SBRT For Metastatic Breast CancerWithdrawnNCT01818999Phase 2
• Impact of Body Weight on Pharmacokinetic Analysis of Doxorubicin + Cyclophosphamide in Breast CancerWithdrawnNCT01542203
• Epigenetic Testing for Breast Cancer Risk StratificationCompletedNCT01501656
• Bootcamp During Neoadjuvant Chemotherapy for Breast CancerCompletedNCT01411787Not applicable
• Cyberknife® Partial Breast Irradiation (PBI) for Early Stage Breast CancerCompletedNCT01162200Phase 1
• Tamoxifen in Preventing Breast Cancer in Women at Increased Risk for Breast CancerTerminatedNCT00096369Phase 2